Back to results
CompletedPhase 3

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)

NCT02932943

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Southern California Research LLC.

Beverly Hills, California, United States

+30 additional locations

View on ClinicalTrials.gov
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01) — TrialFind